Unusual	O
axillary	B:C0684830
metastasis	I:C0684830
of	O
recurrent	O
nasopharyngeal	O
cancer	I:C0153392
:	O
A	O
case	O
report	O
.	O

Unusual	O
axillary	O
metastasis	I:C0684830
of	O
recurrent	O
nasopharyngeal	B:C0153392
cancer	I:C0153392
:	O
A	O
case	O
report	O
.	O

Nasopharyngeal	B:C2931822
carcinoma	I:C2931822
(	O
Nasopharyngeal	O
carcinoma	I:C2931822
)	O
has	O
a	O
high	O
propensity	O
of	O
metastasis	O
.	O

Nasopharyngeal	O
carcinoma	I:C2931822
(	O
Nasopharyngeal	B:C2931822
carcinoma	I:C2931822
)	O
has	O
a	O
high	O
propensity	O
of	O
metastasis	O
.	O

Nasopharyngeal	O
carcinoma	I:C2931822
(	O
Nasopharyngeal	O
carcinoma	I:C2931822
)	O
has	O
a	O
high	O
propensity	O
of	O
metastasis	B:C4255448
.	O

The	O
most	O
commonly	O
described	O
sites	B:C0005898
of	O
distant	O
metastasis	O
are	O
the	O
bones	O
,	O
lungs	O
,	O
and	O
liver	O
,	O
whereas	O
axillary	O
metastasis	I:C0684830
is	O
seldom	O
reported	O
.	O

The	O
most	O
commonly	O
described	O
sites	O
of	O
distant	O
metastasis	B:C4255448
are	O
the	O
bones	O
,	O
lungs	O
,	O
and	O
liver	O
,	O
whereas	O
axillary	O
metastasis	I:C0684830
is	O
seldom	O
reported	O
.	O

The	O
most	O
commonly	O
described	O
sites	O
of	O
distant	O
metastasis	O
are	O
the	O
bones	B:C0262950
,	O
lungs	O
,	O
and	O
liver	O
,	O
whereas	O
axillary	O
metastasis	I:C0684830
is	O
seldom	O
reported	O
.	O

The	O
most	O
commonly	O
described	O
sites	O
of	O
distant	O
metastasis	O
are	O
the	O
bones	O
,	O
lungs	B:C0024109
,	O
and	O
liver	O
,	O
whereas	O
axillary	O
metastasis	I:C0684830
is	O
seldom	O
reported	O
.	O

The	O
most	O
commonly	O
described	O
sites	O
of	O
distant	O
metastasis	O
are	O
the	O
bones	O
,	O
lungs	O
,	O
and	O
liver	B:C0023884
,	O
whereas	O
axillary	O
metastasis	I:C0684830
is	O
seldom	O
reported	O
.	O

The	O
most	O
commonly	O
described	O
sites	O
of	O
distant	O
metastasis	O
are	O
the	O
bones	O
,	O
lungs	O
,	O
and	O
liver	O
,	O
whereas	O
axillary	B:C0684830
metastasis	I:C0684830
is	O
seldom	O
reported	O
.	O

We	O
hereby	O
present	O
the	O
case	O
of	O
a	O
66	O
-	O
year	O
-	O
old	O
man	O
with	O
Nasopharyngeal	B:C2931822
carcinoma	I:C2931822
,	O
cT2N2M0	O
,	O
at	O
diagnosis	O
.	O

We	O
hereby	O
present	O
the	O
case	O
of	O
a	O
66	O
-	O
year	O
-	O
old	O
man	O
with	O
Nasopharyngeal	O
carcinoma	I:C2931822
,	O
cT2N2M0	B:C0475284
,	O
at	O
diagnosis	O
.	O

We	O
hereby	O
present	O
the	O
case	O
of	O
a	O
66	O
-	O
year	O
-	O
old	O
man	O
with	O
Nasopharyngeal	O
carcinoma	I:C2931822
,	O
cT2N2M0	O
,	O
at	O
diagnosis	B:C0011900
.	O

He	O
had	O
completed	O
chemoradiotherapy	B:C0436307
and	O
been	O
disease	O
-	O
free	O
for	O
7	O
years	O
.	O

After	O
that	O
period	O
,	O
late	O
recurrence	B:C2825055
in	O
the	O
form	O
of	O
a	O
solitary	O
axillary	O
lymph	O
node	O
metastasis	O
was	O
detected	O
and	O
confirmed	O
by	O
core	O
-	I:C1318309
needle	I:C1318309
biopsy	I:C1318309
.	O

After	O
that	O
period	O
,	O
late	O
recurrence	O
in	O
the	O
form	O
of	O
a	O
solitary	O
axillary	O
lymph	O
node	O
metastasis	O
was	O
detected	B:C0442726
and	O
confirmed	O
by	O
core	O
-	I:C1318309
needle	I:C1318309
biopsy	I:C1318309
.	O

After	O
that	O
period	O
,	O
late	O
recurrence	O
in	O
the	O
form	O
of	O
a	O
solitary	O
axillary	O
lymph	O
node	O
metastasis	O
was	O
detected	O
and	O
confirmed	B:C0750484
by	O
core	O
-	I:C1318309
needle	I:C1318309
biopsy	I:C1318309
.	O

After	O
that	O
period	O
,	O
late	O
recurrence	O
in	O
the	O
form	O
of	O
a	O
solitary	O
axillary	O
lymph	O
node	O
metastasis	O
was	O
detected	O
and	O
confirmed	O
by	O
core	B:C1318309
-	I:C1318309
needle	I:C1318309
biopsy	I:C1318309
.	O

The	O
lesion	B:C0221198
was	O
chemoresistant	O
but	O
responded	O
to	O
salvage	O
radiotherapy	I:C1522449
at	O
a	O
dose	O
of	O
65	O
Gy	O
in	O
21	O
fractions	O
.	O

The	O
lesion	O
was	O
chemoresistant	B:C1514892
but	O
responded	O
to	O
salvage	O
radiotherapy	I:C1522449
at	O
a	O
dose	O
of	O
65	O
Gy	O
in	O
21	O
fractions	O
.	O

The	O
lesion	O
was	O
chemoresistant	O
but	O
responded	O
to	O
salvage	B:C1522449
radiotherapy	I:C1522449
at	O
a	O
dose	O
of	O
65	O
Gy	O
in	O
21	O
fractions	O
.	O

Post	O
-	O
radiotherapy	O
positron	B:C0032743
emission	I:C0032743
tomography	I:C0032743
scan	I:C0032743
showed	O
no	O
evidence	I:C1518340
of	I:C1518340
disease	I:C1518340
.	O

Post	O
-	O
radiotherapy	O
positron	O
emission	I:C0032743
tomography	I:C0032743
scan	I:C0032743
showed	O
no	B:C1518340
evidence	I:C1518340
of	I:C1518340
disease	I:C1518340
.	O

We	O
suggested	O
that	O
long	B:C1517942
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
of	O
NPC	O
patients	O
is	O
important	O
because	O
a	O
late	O
relapse	I:C4054664
may	O
occur	O
at	O
an	O
unusual	O
site	I:C0005898
.	O

We	O
suggested	O
that	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
of	O
NPC	O
patients	O
is	O
important	O
because	O
a	O
late	B:C4054664
relapse	I:C4054664
may	O
occur	O
at	O
an	O
unusual	O
site	I:C0005898
.	O

We	O
suggested	O
that	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
of	O
NPC	O
patients	O
is	O
important	O
because	O
a	O
late	O
relapse	I:C4054664
may	O
occur	O
at	O
an	O
unusual	B:C0005898
site	I:C0005898
.	O

Aggressive	B:C0376636
management	I:C0376636
of	O
solitary	O
metastasis	O
may	O
achieve	O
good	O
outcome	O
.	O

Aggressive	O
management	I:C0376636
of	O
solitary	O
metastasis	B:C4255448
may	O
achieve	O
good	O
outcome	O
.	O

